NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
1-Year Return
50.66%
This Quarter Return
+20.96%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$976M
AUM Growth
+$122M
(+14%)
Cap. Flow
-$90.2M
Cap. Flow
% of AUM
-9.23%
Top 10 Holdings %
Top 10 Hldgs %
19.05%
Holding
237
New
35
Increased
79
Reduced
34
Closed
30
Top Buys
| 1 |
REV Group
REVG
|
$15.9M |
| 2 |
Shake Shack
SHAK
|
$7.98M |
| 3 |
Skywest
SKYW
|
$7.11M |
| 4 |
Viking Therapeutics
VKTX
|
$6.56M |
| 5 |
OSI Systems
OSIS
|
$6.18M |
Top Sells
| 1 |
Super Micro Computer
SMCI
|
$23.1M |
| 2 |
Celsius Holdings
CELH
|
$14.8M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$10.3M |
| 4 |
Cytokinetics
CYTK
|
$8.56M |
| 5 |
e.l.f. Beauty
ELF
|
$8.14M |
Sector Composition
| 1 | Technology | 26.72% |
| 2 | Industrials | 19.31% |
| 3 | Healthcare | 13.08% |
| 4 | Financials | 9.58% |
| 5 | Consumer Discretionary | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Toll Brothers
TOL
$14B
| $597K | 0.06% |
+4,611
| New | +$597K |
|
152
Domino's
DPZ
$15.7B
| $588K | 0.06% |
1,183
+337
| +40% | +$167K |
|
153
Sarepta Therapeutics
SRPT
$1.93B
| $584K | 0.06% |
4,514
+1,185
| +36% | +$153K |
|
154
Live Nation Entertainment
LYV
$37.8B
| $583K | 0.06% |
+5,510
| New | +$583K |
|
155
JB Hunt Transport Services
JBHT
$14.1B
| $580K | 0.06% |
2,910
+83
| +3% | +$16.5K |
|
156
Ralph Lauren
RL
$19.4B
| $566K | 0.06% |
+3,015
| New | +$566K |
|
157
CoStar Group
CSGP
$37.7B
| $557K | 0.06% |
+5,770
| New | +$557K |
|
158
Tesla
TSLA
$1.09T
| $546K | 0.06% |
3,108
-1,503
| -33% | -$264K |
|
159
Axon Enterprise
AXON
$57.3B
| $543K | 0.06% |
+1,735
| New | +$543K |
|
160
First Citizens BancShares
FCNCA
$26B
| $535K | 0.05% |
327
| – | – |
|
161
Deckers Outdoor
DECK
$18.4B
| $511K | 0.05% |
3,258
-498
| -13% | -$78.1K |
|
162
WillScot Mobile Mini Holdings
WSC
$4.3B
| $455K | 0.05% |
+9,780
| New | +$455K |
|
163
Oracle
ORCL
$626B
| $432K | 0.04% |
3,442
+587
| +21% | +$73.7K |
|
164
Ginkgo Bioworks
DNA
$691M
| $390K | 0.04% |
8,415
| – | – |
|
165
Atlassian
TEAM
$44.1B
| $358K | 0.04% |
1,834
| – | – |
|
166
Legend Biotech
LEGN
$6.46B
| $335K | 0.03% |
5,976
-20,674
| -78% | -$1.16M |
|
167
Texas Roadhouse
TXRH
$11.3B
| $335K | 0.03% |
2,166
-208
| -9% | -$32.1K |
|
168
Snowflake
SNOW
$74B
| $228K | 0.02% |
1,410
-1,106
| -44% | -$179K |
|
169
Axcelis
ACLS
$2.48B
| – | – |
-18,112
| Closed | -$2.35M |
|
170
argenx
ARGX
$44.9B
| – | – |
-15,919
| Closed | -$6.06M |
|
171
Baker Hughes
BKR
$45.7B
| – | – |
-47,041
| Closed | -$1.61M |
|
172
Cabaletta Bio
CABA
$141M
| – | – |
-54,586
| Closed | -$1.24M |
|
173
Sprinklr
CXM
$2.03B
| – | – |
-207,997
| Closed | -$2.5M |
|
174
CoreCivic
CXW
$2.13B
| – | – |
-115,398
| Closed | -$1.68M |
|
|
175
Cytokinetics
CYTK
$5.95B
| – | – |
-102,572
| Closed | -$8.56M |
|